Chronic migraine is a disabling neurological disorder defined by headaches occurring on at least fifteen days per month, with migraine features on at least eight of those days. Unlike episodic migraine, chronic migraine significantly impacts daily functioning, work productivity, sleep quality and emotional well-being. Although its mechanisms are complex, advances in neuroscience have greatly improved diagnosis and treatment options in recent years.
What chronic migraine is
Migraine is not a simple headache but a complex neurovascular condition involving hypersensitivity of the central nervous system. In chronic migraine, the brain becomes increasingly reactive to light, sounds, smells and mechanical stimuli. Repeated attacks lead to changes in pain pathways, causing a continuous state of neuronal hyperexcitability. Over time, the threshold for triggering pain lowers, making attacks more frequent and persistent.
Main causes and contributing factors
The exact cause is multifactorial. Genetics play a significant role, as migraine often appears in families. Environmental and lifestyle factors contribute to chronicization, including excessive use of painkillers, stress, poor sleep quality, hormonal fluctuations, dehydration and irregular meals. Some individuals develop chronic migraine after years of episodic attacks, sometimes triggered by a period of intense stress or a major health event such as infection or trauma. Sensory overload—bright screens, strong smells, loud environments—may also perpetuate attacks in predisposed individuals.
Symptoms and stages
Chronic migraine can manifest through several phases:
Prodrome: occurs hours or even days before the headache. Patients may notice irritability, fatigue, neck stiffness, frequent yawning or difficulty concentrating.
Aura (in some patients): reversible neurological symptoms such as flashing lights, zig-zag lines, blind spots or tingling in face and hands. Not all patients experience aura.
Headache phase: pulsating or pressure-like pain, often unilateral but sometimes bilateral. The pain intensifies with routine physical activity and is frequently accompanied by nausea, vomiting, sensitivity to light (photophobia) and noise (phonophobia).
Postdrome: a “migraine hangover” characterised by exhaustion, cognitive slowing and general weakness.
Diagnosis
Diagnosis is clinical and based on frequency, duration and characteristics of attacks. Neurologists evaluate history, trigger patterns and response to previous treatments. Imaging tests such as MRI are used only when symptoms suggest secondary causes (for example sudden new headaches or neurological deficits). Identifying medication overuse is essential, as this is one of the most common reasons episodic migraine becomes chronic.
Current treatment strategies
Management of chronic migraine requires a combined approach. Acute treatments such as triptans, gepants or anti-inflammatory drugs help reduce attack severity but must be used responsibly to avoid medication overuse. Preventive therapy is the cornerstone of long-term management. Options include:
Preventive oral medications: beta-blockers, anticonvulsants and certain antidepressants can stabilise the nervous system and reduce attack frequency.
Botulinum toxin type A: an established and effective option for chronic migraine, administered through targeted injections every twelve weeks to reduce pain pathway activation.
CGRP-targeted therapies: monoclonal antibodies that block the calcitonin gene-related peptide pathway, one of the most promising breakthroughs in migraine treatment. These injections are typically given monthly or quarterly.
Lifestyle adjustments: regular sleep, hydration, balanced meals, reduced screen exposure, stress management techniques and moderate physical activity can significantly improve symptoms. Identifying individual triggers helps tailor long-term strategies.
Long-term outlook
Chronic migraine can be extremely limiting, but with proper treatment many patients experience substantial improvement. Early intervention, avoidance of medication overuse, personalised preventive therapy and consistent lifestyle measures remain essential for restoring quality of life. As scientific understanding advances, new therapeutic options continue to emerge, offering hope to millions of individuals living with this complex neurological condition.
Copyright © Tutti i diritti sono riservati – Salute33